Lotte Biologics
NDC Database

Lotte Biologics

NDC Database

National Drug Code (NDC) records including drug products, NDC numbers, nonproprietary names, dosage forms, strengths, labelers and marketing information.

Bulk Ingredient
  • Total Records 4
  • Latest Marketing Date 2015-11-30
  • Data Source FDA
  • First Marketing Date 2011-03-25
Company Overview

Company

Lotte Biologics

Country

South Korea

Website

Visit Website

Email

Social Profiles

LinkedIn
Company Snapshot

Lotte Biologics

LOTTE World Tower, 300 Olympic-ro, Songpa-gu, Seoul, Korea 05551

South Korea

www.lottebiologics.com/en/ View on Map
NDC Records ( 4 records )
2011
15 Jun
Bulk Ingredient NDC: 83157-0371

Nonproprietary Name

BELATACEPT

Dosage Form

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Strength

1 kg/kg

Labeler

Lotte Biologics USA, LLC

Marketing Category

BULK INGREDIENT

83157-0371

Substance

BELATACEPT

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2011-06-15

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2015
30 Nov
Bulk Ingredient NDC: 83157-2291

Nonproprietary Name

Elotuzumab

Dosage Form

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Strength

1 kg/kg

Labeler

Lotte Biologics USA, LLC

Marketing Category

BULK INGREDIENT

83157-2291

Substance

ELOTUZUMAB

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2015-11-30

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2011
25 Mar
Bulk Ingredient NDC: 83157-2327

Nonproprietary Name

IPILIMUMAB

Dosage Form

INJECTION

Strength

1 kg/kg

Labeler

Lotte Biologics USA, LLC

Marketing Category

BULK INGREDIENT

83157-2327

Substance

IPILIMUMAB

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2011-03-25

End Marketing Date

-

Listing Record Certified Through

2026-12-31

2014
22 Dec
Bulk Ingredient NDC: 83157-3772

Nonproprietary Name

Nivolumab

Dosage Form

INJECTION

Strength

1 kg/kg

Labeler

Lotte Biologics USA, LLC

Marketing Category

BULK INGREDIENT

83157-3772

Substance

NIVOLUMAB

Product Type

BULK INGREDIENT

DEA Schedule

Start Marketing Date

2014-12-22

End Marketing Date

-

Listing Record Certified Through

2026-12-31

Related Databases
  • FDA Inspections
    7 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    4 View
  • FDA Approved Drugs Database
    0 View
  • Drug Prices in Switzerland
    0 View
NDC Type Breakdown
4 total
  • Bulk Ingredient
Official Source

NDC data is based on publicly available National Drug Code information from the U.S. Food and Drug Administration (FDA).

Visit FDA NDC Directory
NDC Record Details Preview

Explore important National Drug Code information available in the records above.

NDC

83157-0371

Nonproprietary Name

BELATACEPT

Labeler

Lotte Biologics USA, LLC

Dosage Form

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

FDA NDC Data

National Drug Code information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized NDC records

NDC data is based on publicly available U.S. Food and Drug Administration (FDA) National Drug Code information.

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit